-+ 0.00%
-+ 0.00%
-+ 0.00%

Reported Earlier, Organogenesis Reports PuraPly AM Meets Primary Endpoint In Randomized Controlled Trial, Demonstrating Statistically Significant DFU Wound Closure At 12 Weeks

Benzinga·04/07/2026 06:03:55
Listen to the news
  • Statistically significant (p<0.0477) DFU wound closure at 12 weeks
  • RCT compared PuraPly®AM plus standard of care to standard of care alone
  • Results strengthen existing clinical evidence supporting future coverage